Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | PREP | P48147 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25510403 | 0.90 | TP53 (0.35) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL7193989 | 0.84 | CYP1A1 (0.46) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL17318153 | 0.83 | CA12 (0.47) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL413810 | 0.82 | HSP90AA1 (0.47) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL37002 | 0.81 | PREP (0.43) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL717551 | 0.81 | CA12 (0.41) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL36825 | 0.78 | NPSR1 (0.34) | CA12CA1CA9 | |
| SCHEMBL21356550 | 0.77 | ESR1 (0.50) | CA12CA1CA9PREPCYP1A1 | |
| SCHEMBL14834242 | 0.76 | CA12 (0.37) | CA12CA1CA9PREP | |
| SCHEMBL23723314 | 0.75 | CA12 (0.42) | CA12CA1CA9PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20190276575-A1 | METHOD FOR PRODUCING RESIN AND METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION | FUJIFILM CORPORATION (JP) | 2019-09-12 | — | — | US | disclosed |
| EP-2448900-B1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORP (JP) | 2017-04-26 | — | — | EP | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-9365660-B2 | Anionic polymerization initiators and processes | BRIDGESTONE CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20120136128-A1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| EP-2448900-A2 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | Bridgestone Corporation (JP) | 2012-05-09 | — | — | EP | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| EP-2391658-A1 | MOLECULARLY IMPRINTED POLYMERS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-12-07 | — | — | EP | disclosed |
| WO-2011008501-A2 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORPORATION (JP) | 2011-01-20 | — | — | WO | disclosed |
| WO-2010085851-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010085851-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CA12 1571/4885CA1 2621/4885CA9 397/4885 |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CA12 1571/4885CA1 2621/4885CA9 397/4885 |
| US-20120136128-A1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | AP1M1, AP2M1, CCNE2 | CA12 2082/4885CA1 2210/4885CA9 3146/4885 |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CA12 1571/4885CA1 2621/4885CA9 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.